A AGROPECUÁRIA E AS INDÚSTRIAS TRADICIONAIS NO DESENVOLVIMENTO REGIONAL PARANAENSE NO PERÍODO DE 1970 A 2000

Este artigo analisa as transformações espaciais ocorridas na estrutura produtiva das Áreas Mínimas Comparáveis (AMCs) paranaenses, especificamente dos setores agropecuário e das indústrias tradicionais, no período de 1970 a 2000. Utilizou-se a abordagem teórica da base econômica de Douglas North para fundamentar a análise e o Quociente Locacional para identificar as AMCs que tinham esses setores como básicos no período analisado. Os resultados mostraram uma mudança espacial da distribuição dos setores analisados: o setor agropecuário se difundiu e o setor das indústrias tradicionais se adensou em AMCs específicas do Estado do Paraná, principalmente em Guarapuava, Irati, Pinhão, Palmas, Bituruna, General Carneiro, União da Vitória, Porto Vitória, Paula Freitas, Mangueirinha, localizadas na Mesorregião Centro Sul; e nas AMCs de Mariópolis, Clevelândia, Coronel Vivida, Francisco Beltrão, Ampére, localizadas na Mesorregião Sudoeste do Paraná. Assim, a capacidade e a interação da base econômica da agropecuária e das indústrias tradicionais das AMCs (regiões) paranaenses foram responsáveis pela manutenção, difusão e a diversificação dos ramos de atividades básicas e alavancaram os ramos de atividades não-básicas da indústria tradicional

Different Clinical Phenotypes of Embolic Stroke of Undetermined Source: A Subgroup Analysis of 86 Patients

Embolic strokes of undetermined source (ESUS) represent a rather recent diagnostic entity under clinical research for relapse prevention in cryptogenic stroke patients. Despite strict diagnostic criteria, ESUS definition ignores major clinical and radiological aspects, so including heterogeneous cases and probably influencing trial results. This study researches clinically relevant phenotypes among ESUS patients

Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis

Background and purpose The core manifestations of leucine-rich glioma-inactivated 1 (LGI1) autoantibody-mediated encephalitis are limbic encephalitis and faciobrachial dystonic seizures. Agrypnia excitata (AE) is a rare syndrome characterized by sleep-wake cycle disruption, autonomic hyperactivation and episodes of oneiric stupor. Only a few diseases are known to present with AE. An autoimmune etiology must be considered when accompanied by neuromyotonia. A case of anti-LGI1 encephalitis presenting with AE is reported. Methods Detailed clinical, video-polysomnographic, laboratory, radiological and long-term follow-up assessments were performed. Results A previously healthy 58-year-old man was referred for a rapidly progressive change in mental status, characterized by persistent drowsiness and confusion, accompanied by frequent episodes of unconscious gestures ranging from simple stereotyped movements to more complex actions mimicking various daily activities. Other symptoms included tachycardia, hyperhidrosis, mild hyponatremia, rare faciobrachial dystonic seizures, and a single generalized tonic-clonic seizure, but no neuromyotonia. Prolonged video-polysomnography excluded epileptic activity and showed continuous monomorphic slowing of background activity not consistent with a regular wakefulness or sleep state. A brain magnetic resonance imaging scan was unremarkable. Brain fluorodeoxyglucose positron emission tomography revealed hypermetabolism of the hippocampi, amygdala and basal ganglia. Anti-LGI1 antibodies were detected in the cerebrospinal fluid. The sleep disorder resolved progressively after starting immunotherapy. Conclusions Agrypnia excitata can be a dominant, treatable manifestation of anti-LGI1 encephalitis. Oneiric stupor episodes are a useful clinical feature for establishing diagnostic suspicion and could provide a window to understanding the mechanisms behind some movement disorders in autoimmune encephalitis

Progressive and Fatal Brainstem Stroke in Systemic Giant Cell Arteritis

9N/AreservedmixedmixedPoretto, Valentina; Piffer, Silvio; Bignamini, Valeria; Tranquillini, Enzo; Donner, Davide; Cavatorta, Francesco Paolo; Barbareschi, Mattia; Petralia, Benedetto; Giometto, BrunoPoretto, Valentina; Piffer, Silvio; Bignamini, Valeria; Tranquillini, Enzo; Donner, Davide; Cavatorta, Francesco Paolo; Barbareschi, Mattia; Petralia, Benedetto; Giometto, Brun

Heart Team for Left Atrial Appendage Occlusion: A Patient-Tailored Approach

Background and Purpose: Left atrial appendage occlusion (LAAO) is an accepted therapeutic option for stroke prevention; however, the ideal technique and device have not yet been identified. In this study we evaluate the potential role of a heart team approach for patients contraindicated for oral anticoagulants and indicated for left atrial appendage closure, to minimize risk and optimize benefit in a patient-centered decision-making process. Methods: Forty patients were evaluated by the heart team for appendage occlusion. Variables considered were CHA2DS2VASc, HASBLED, documented blood transfusions, comorbidities, event forcing anticoagulant interruption, past medical history, anatomy of the left atrial appendage, and patient quality of life. Twenty patients had their appendage occluded percutaneously (65% male, mean age 72.3 ± 7.5, mean CHA2DS2VASc 4.2 ± 1.5, mean HASBLED 3.5 ± 1.1). The other twenty underwent thoracoscopic occlusion (65% male, mean age of 74.9 ± 8, mean CHA2DS2VASc 6.0 ± 1.5, HASBLED mean 5.4 ± 1.4). Percutaneous patients were on dual antiplatelet therapy for the first three months and aspirin thereafter, whereas the others received no anticoagulant/antiplatelet therapy from the day of surgery. Follow up included TEE, CT scan, and periodical clinical evaluation. Results: Mean duration of procedures and hospital stay were comparable. All patients had complete exclusion of the appendage; at a mean follow up of 33.1 ± 14.1 months, no neurological or hemorrhagic events were reported. Conclusions: A heart team approach may improve the decision-making process for stroke and hemorrhage prevention, where LAAO is a therapeutic option. Percutaneous and thoracoscopic appendage occlusion seem to be comparably safe and effective. An epicardial LAAO could be advisable in patients for whom the risk of bleeding is estimated as being too high for post-procedural antiplatelet therapy